Involvement of αvβ5 integrin in the establishment of autocrine TGF-β signaling in dermal fibroblasts derived from localized scleroderma

被引:71
作者
Asano, Yoshihide
Ihn, Hironobu
Jinnin, Masatoshi
Mimura, Yoshihiro
Tamaki, Kunihiko
机构
[1] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Dermatol & Plast & Reconstruct Surg, Kumamoto 8608556, Japan
[2] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan
关键词
D O I
10.1038/sj.jid.5700331
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Localized scleroderma ( LSc) is a connective tissue disorder limited to skin and subcutaneous tissue, which may share pathogenic processes with systemic sclerosis ( SSc). We previously demonstrated that upregulated expression of integrin alpha v beta 5 might contribute to autocrine TGF-beta signaling in SSc fibroblasts. Based on these data, we presently focused on alpha v beta 5 and assessed its involvement in pathogenesis of LSc. We initially demonstrated that LSc fibroblasts might be activated by the stimulation of autocrine TGF-beta. Consistent with SSc fibroblasts, expression levels of alpha v beta 5 were elevated in LSc fibroblasts in vitro and in vivo. Anti- alpha v beta 5 antibody partially reversed expression levels of type I procollagen and MMP- 1 and constitutive DNA - Smad3 binding in LSc fibroblasts. In LSc fibroblasts pretreated with antisense TGF-b1, exogenous latent TGF- b 1 stimulation increased expression of type I procollagen in an alpha v beta 5- dependent manner. The luciferase activities of TMLC cells, Mv1Lu cells stably expressing a portion of the plasminogen activator inhibitor 1 promoter, co-cultured with LSc fibroblasts were significantly elevated compared with those co-cultured with normal fibroblasts and were significantly reduced in the presence of anti-a v b 5 antibody. Anti-alpha v beta 5 antibody reversed the myofibroblastic features of LSc fibroblasts. These results indicate that upregulated expression of a v b 5 contributes to autocrine TGF-beta signaling in LSc fibroblasts.
引用
收藏
页码:1761 / 1769
页数:9
相关论文
共 42 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]   Increased expression of integrin αvβ5 induces the myofibroblastic differentiation of dermal fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Tamaki, K .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (02) :499-510
[4]   Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Mimura, Y ;
Tamaki, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7708-7718
[5]   Involvement of αVβ5 integrin-mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Mimura, Y ;
Tamaki, K .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2897-2905
[6]   Differential effects of the immunosuppressant FK-506 on human α2(I) collagen gene expression and transforming growth factor β signaling in normal and scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Mimura, Y ;
Tamaki, K .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1237-1247
[7]   Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Jinnin, M ;
Mimura, Y ;
Tamaki, K .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :7123-7135
[8]   Increased expression levels of integrin αvβ5 on scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Kubo, M ;
Tamaki, K .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1275-1292
[9]   Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Kubo, M ;
Tamaki, K .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (02) :253-264
[10]  
BUCKINGHAM RB, 1978, J LAB CLIN MED, V92, P5